← Eichor
Study identifier: NCT02560805 Synced from ClinicalTrials.gov · July 29, 2026
● Recruiting

Role of Sympathetic Overactivity and Angiotensin II in PTSD and CV

Condition: Stress Disorders, Post-Traumatic  ·  Sponsor: Emory University

PhasePhase 2
Planned participants134
Who can joinAll sexes, 18 Years to 65 Years
Healthy volunteersYes

About this study

The purpose of this study is to find out why patients with post-traumatic stress disorder (PTSD) have an increased risk for heart disease and high blood pressure later in life. A second purpose is to find out what causes PTSD patients to have high adrenaline levels during stress. This study will also test if a medicine called losartan improves high adrenaline levels in patients with PTSD and if a certain gene that has to do with high blood pressure might be associated with high adrenaline levels.

This description comes directly from the study's public registry record.

Talk to the study team

Deirdre Dixon  ·  404-321-6111  ·  deirdre.dixon@emory.edu

Dana DaCosta  ·  404-727-7762  ·  drdacos@emory.edu

Always discuss trial participation with your own doctor first.

Locations (1)

Atlanta VA Medical CenterDecatur, Georgia, United StatesRecruiting

Follow this study

Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.

We email about this public record only. Unsubscribe anytime with one click. Never medical advice.

Is this your study? This page was generated automatically from the public registry record. Sponsors can claim it — free — to add branding and verified contact routing. Claim this page →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.

Source record: clinicaltrials.gov/study/NCT02560805